CARLSBAD, Calif. & SOUTH SAN FRANCISCO, Calif.–Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, announced today its partnership with BayBio, a leading voice for the life sciences industry in Northern California.

“BayBio is a vital voice for California’s life sciences industry and is an effective leader in the state’s capital. This partnership enables us to support BayBio’s mission to create growth in areas such as regenerative cell therapy, and help to expedite scientific discoveries using our most innovative tools,” said Bernd Brust, Invitrogen’s Senior Vice President of Worldwide Sales and Marketing.

The BayBio Partner Program recognizes the life sciences industry’s leaders and brings unique opportunities to the employees of BayBio Partners, including meetings with California’s elected officials, policy makers and other opinion leaders from across the globe.

“Invitrogen’s growing influence in the life sciences community can have a profound impact in supporting this important industry in the State of California,” said Matthew M. Gardner, President and CEO of BayBio. “This important relationship creates new resources that allow the life sciences industry to reach greater heights in the Golden State by providing more cures, treatments and products for the world’s population.”